Keyphrases
Parkinson's Disease
100%
Positron Emission Tomography
34%
Huntington's Disease
33%
Dystonia
28%
Radioligand
18%
Levodopa
17%
Striatal
17%
Cervical Dystonia
17%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
16%
Deep Brain Stimulation
16%
Parkinsonism
14%
Radiotracer
14%
Idiopathic Parkinson's Disease
12%
Receptor Binding
12%
Vesicular Acetylcholine Transporter (VAChT)
12%
D2 Receptor
11%
Dopamine
11%
Age of Onset
11%
Striatum
10%
Regional Cerebral Blood Flow (rCBF)
10%
Alpha-synuclein (α-syn)
9%
Parkinson Patients
9%
Sphingosine-1-phosphate Receptor (S1PR)
9%
Blepharospasm
8%
Dopamine D2 Receptor (DRD2)
8%
Subthalamic nucleus
8%
Pathophysiology
8%
Movement Disorders
8%
Premanifest Huntington's Disease
8%
Radiosynthesis
8%
Blood Flow
8%
Alzheimer's Disease
7%
Dementia
7%
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
7%
Flow Response
7%
Rodents
7%
Unified Parkinson's Disease Rating Scale (UPDRS)
7%
Basal Ganglia
7%
Gait
7%
Functional Connectivity
7%
Putamen
6%
D2-like
6%
Macaque
6%
Patients with Parkinson's Disease
6%
Neurodegenerative Diseases
6%
Striatal Dopamine
6%
Focal Dystonia
6%
Tremor
6%
Cerebral Blood Flow
6%
Neuroimaging
5%
Neuroscience
Parkinson's Disease
98%
Positron Emission Tomography
39%
Dystonia
30%
Fluorine-18
28%
In Vivo
21%
Deep Brain Stimulation
20%
Positron Emission Tomography
20%
Huntington's Disease
19%
L-DOPA
18%
Subthalamic Nucleus
17%
Receptor
16%
Parkinsonism
16%
Radioligand
15%
Tremor
13%
Spasmodic torticollis
13%
In Vitro
11%
Dopaminergic
11%
Receptor Binding
10%
Putamen
10%
Stereotypic Movement Disorder
9%
Alzheimer's Disease
8%
Vesicular Acetylcholine Transporter
8%
Striatum
8%
Functional Connectivity
7%
Tetrahydropyridine
7%
Magnetic Resonance Imaging
7%
Dopamine Receptor D2
7%
Synuclein
7%
Sphingosine-1-Phosphate Receptor
7%
Basal Ganglia
6%
Familial Parkinson's Disease
6%
Cerebellum
5%
Metabolic Pathway
5%
Amyloid Protein
5%
Behavior (Neuroscience)
5%
Dopamine Receptor D3
5%
Haplotype
5%
Neurodegenerative Disorder
5%
Resting-State Functional Connectivity
5%